ViiV Healthcare is expected to introduce the latest in antiretroviral treatment in South Africa’s private sector in June at about R720 per month.

About one in nine South African tuberculosis (TB) patients are also living with type 2 diabetes, according to Stellenbosch University medical biologist Dr Katharina Ronache. Ronacher warns rising rates of co-infection could have consequences for treatment outcomes.